Topics

Latest "Inseego Corp" News Stories

04:04 EST 28th February 2020 | BioPortfolio

Here are the most relevant search results for "Inseego Corp" found in our extensive news archives from over 250 global news sources.

More Information about Inseego Corp on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Inseego Corp for you to read. Along with our medical data and news we also list Inseego Corp Clinical Trials, which are updated daily. BioPortfolio also has a large database of Inseego Corp Companies for you to search.

Showing "Inseego Corp" News Articles 1–25 of 117

Relevant

IONIC BRANDS CORP: IONIC BRANDS Launches Investor Group Community On 8020 Connect Platform; John Gorst, CEO & Chairman Converts Debt Into Shares

TACOMA, WA / ACCESSWIRE / February 11, 2020 / IONIC BRANDS CORP. (CSE:IONC)(OTCPINK:IONKF)(FRA:1B3) ("IONIC BRANDS" or the "Company") announces it has launched an Investor Group Community on 8020 C...


PDS Biotechnology Corp. Announces Clinical Collaboration with Merck

BERKELEY HEIGHTS, N.J., Oct. 03, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of multi-functional immunotherapeutic products, today announced a modification of the clinical trial collaboration agreement with a subsidiary of Merck (known as MSD outside the United States a...

Ascent Industries Corp. Default Status Report

VANCOUVER, British Columbia, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. (CSE: ASNT) (“Ascent” or the “Company”) is providing this default status report pursuant to National Policy 12-203 Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203") and applicable policy of the British Columbia Securities Commission applicable to companies, such as Ascent, that...


Helix BioPharma Corp. Closes $7.0 Million Private Placement

RICHMOND HILL, Ontario, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a private placement financing of 13,725,000 units of the Company and the disposition of a 25% stake of its wholly-owned...

Helix Biopharma Corp. to Present at RHK Capital Conference in New York

RICHMOND HILL, Ontario, July 24, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announces that it will be presenting at the RHK Capital 2019 Disruptive Growth & Healthcare Conference (www.disruptnyc.com). RHK Capital’s Disruptive Gr...

Helix BioPharma Corp. Closes $3.0 Million Private Placement

RICHMOND HILL, Ontario, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a private placement financing of 2,940,000 units of the Company (“Units”) and the disposition of shares of the Comp...

MustGrow Biologics Corp. Featured in Exclusive NetworkNewsWire Broadcast

NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and bio-fertilizers, today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibilit...

Blueberries Medical Corp. Closes Over-Subscribed Private Placement

Not for distribution into the United States or to U.S. newswire services TORONTO, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce it has closed its over-subscribed, non-brokered private ...

Helix BioPharma Corp. to Present at the Biotech Showcase Conference in San Francisco

RICHMOND HILL, Ontario, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has been selected to present at the Biotech Showcase Conference on Tuesday, January 14, 2020 at 11:00am (PT) at Hilton San Francis...

Helix BioPharma Corp. Announces Fiscal 2019 Year-End Results

RICHMOND HILL, Ontario, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the year ended July 31, 2019. FINANCIAL REVIEW The Company recorded a net loss and total comprehensive loss of $7,526,000 and $8,625,000 (a loss per co...

Helix Biopharma Corp. Receives U.S. FDA Approval for Phase Ib/II Pancreatic Trial

RICHMOND HILL, Ontario, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced that it has received approval from the U.S. Food and Drug Administration (“FDA”), to initiate a Phase Ib/II study of L-DOS47 and doxorubicin in ad...

Helix BioPharma Corp. Announces Fiscal First Quarter 2020 Results

RICHMOND HILL, Ontario, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the first quarter of fiscal 2020 ending October 31, 2019. OVERVIEW The Company recorded a net loss and total comprehensive loss, including n...

Zomedica Pharmaceuticals Corp. Announces Year End 2019 Financial Results

ANN ARBOR, Mich., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic company, announced consolidated financial results for the year ended December 31, 2019. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under accounting principles generally accepted in the United...

Smart Cannabis Corp’s (SCNA) CBD and Hemp Products Are Developed From Customers' Inspirations

IRVINE, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Smart Cannabis Corp. (OTC PINKSHEETS: SCNA) is pleased to share the inspirations behind Dawn Norby’s successful development and production of Budding Botanicals’ CBD and Hemp retail product lines of Salves, Tinctures, Candies, Capsules and Pet Treats. One of Budding Botanicals’ goals has been to appeal to its broad array of customer...

Smart Cannabis Corp. (SCNA) Commences Retail Sales with Acquisition of CBD and Hemp Operations

IRVINE, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Smart Cannabis Corp. (OTC PINKSHEETS: SCNA) Smart Cannabis Corp. (“Company’) is pleased to announce that its new executive management has diversified the Company’s business strategies with the acquisition of a CBD and hemp retail operations.  In 2019 3rd Quarter, the Company appointed Mark Cheung as its interim CEO who sought out ...

Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study

RICHMOND HILL, Ontario, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced the start of enrollment and screening in the Company’s Phase lb/ll clinical development program for previously treated patien...

Diomics Corp. Announces Development of Intellectual Property and Patents Related to the Identification of Airborne Pathoge

DiomatTM Technology Can Identify Deadly Airborne Pathogens and be Deployed in Fixed Structures Such as Aircraft, Buildings, Train Systems and the like  SAN DIEGO, CA, Feb. 05, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Diomics Corporation, a leader in forensic, diagnostic, and therapeutic science since 2009, today announced that it has developed intellectual property and patents r...

Helix BioPharma Corp. and Moffit Cancer Centre to Present at World Molecular Imaging Congress

RICHMOND HILL, Ontario, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to announce that they, together with Moffitt Cancer Center (“Moffitt”), will be presenting a poster entitled “Pharmacodynamics of target...

Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference

RICHMOND HILL, Ontario, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that Dr. Heman Chao, Helix’s Chief Executive Officer, will be presenting at NobleCon - Noble Capital Markets’ Sixteenth Annual In...

Update: Diomics Corp. Announces Development of Intellectual Property and Patents Related to the Identification of Airborne Pathogens

DiomatTM Technology Can Identify Deadly Airborne Pathogens and be Deployed in Fixed Structures Such as Aircraft, Buildings, Train Systems and the Like  SAN DIEGO, CA, Feb. 05, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE –Diomics Corporation, a leader in forensic, diagnostic, and therapeutic science since 2009, today announced that it has developed intellectual property and patent...

Smart Cannabis Corp’s (SCNA) new Budding Botanicals acquisition offers exciting line of CBD and Hemp Products

IRVINE, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Smart Cannabis Corp. (the “Company”) (OTC PINKSHEETS: SCNA) is pleased to provide further details of its new Budding Botanicals’ line of CBD and hemp products for retail sales.  Budding Botanicals offers CBD Tinctures ranging in size from 100 mg to 1,500 mg, CBD Salves (in 2 versions made with or without THC), CBD 25 mg Capsules, ...

Dawn Norby Joins Smart Cannabis Corp (SCNA) to Head Up Budding Botanicals’ CBD and Hemp Retail Operations

IRVINE, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Smart Cannabis Corp. (OTC PINKSHEETS: SCNA) Smart Cannabis Corp. is pleased to provide further details regarding its acquisition of Budding Botanicals’ CBD and hemp retail sales operations. Budding Botanicals grows, processes, makes, bottles & packages, and sells 100% organic CBD products.  It grows its products indoors organicall...

Cannabis Suisse Corp. is Happy to Announce the Launching of a New Product in Our Retail Brand Alpine Cannabis

ALPINE CANNABIS CBD PURE BASE: BOOST YOUR E-LIQUIDS  Dietikon, Switzerland, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Alpine Cannabis CBD Pure Base is an e-liquid for electronic cigarettes. It’s an amazing boost of CBD to any favorite e-liquids and comes with various levels of CBD strengths. CBD is a compound found and extracted from specific hemp strains. Contrary to ...

Tauriga Sciences, Inc. Changes Subsidiary Name to Tauriga Pharma Corp. to Reflect the Ongoing Development of Pharmaceutical Anti-Nausea Product

NEW YORK, NY, Jan. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has amended, ...

XFRA XBX: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL CAMBREX CORP...


Quick Search

News Quicklinks